MedicalCodify.com
Search Term or Code: Advanced Search 
Geek Mode


Measure: CMS130

Colorectal Cancer Screening

Measure Versions

eMeasure Code Measure Year Full Version Number Title
CMS130v12 2024 12.0.000 Colorectal Cancer Screening
CMS130v11 2023 11 Colorectal Cancer Screening
CMS130v10 2022 10.0.000 Colorectal Cancer Screening
CMS130v9 2021 9.2.000 Colorectal Cancer Screening
CMS130v8 2020 8.4.000 Colorectal Cancer Screening
CMS130v7 2019 7.2.000 Colorectal Cancer Screening
CMS130v6 2018 6.1.000 Colorectal Cancer Screening
CMS130v5 2017 5.0.000 Colorectal Cancer Screening

Description

Percentage of patients 45-75 years of age who had appropriate screening for colorectal cancer.

Guidance

Patient Group Definitions

Group Description Instructions Links
Initial PopulationPatients 46-75 years of age by the end of the measurement period with a visit during the measurement periodWebchart Instructions
DenominatorEquals Initial PopulationWebchart Instructions
Denominator ExclusionsExclude patients who are in hospice care for any part of the measurement period. Exclude patients with a diagnosis or past history of total colectomy or colorectal cancer. Exclude patients 66 and older by the end of the measurement period who are living long term in a nursing home any time on or before the end of the measurement period. Exclude patients 66 and older by the end of the measurement period with an indication of frailty for any part of the measurement period who also meet any of the following advanced illness criteria: - Advanced illness with two outpatient encounters during the measurement period or the year prior - OR advanced illness with one inpatient encounter during the measurement period or the year prior - OR taking dementia medications during the measurement period or the year prior Exclude patients receiving palliative care for any part of the measurement period.Webchart Instructions
NumeratorPatients with one or more screenings for colorectal cancer. Appropriate screenings are defined by any one of the following criteria: - Fecal occult blood test (FOBT) during the measurement period - FIT-DNA during the measurement period or the two years prior to the measurement period - Flexible sigmoidoscopy during the measurement period or the four years prior to the measurement period - CT Colonography during the measurement period or the four years prior to the measurement period - Colonoscopy during the measurement period or the nine years prior to the measurement periodWebchart Instructions
Numerator ExclusionsNot ApplicableWebchart Instructions
Denominator ExceptionsNone

Details

Full eMeasure Code eMeasure Identifier Measure Year Version NQF # GUID
CMS130v11 130 2023 11 0034 aa2a4bbc-864f-45ee-b17a-7ebcc62e6aac
Steward Developer Endorsed By
National Committee for Quality Assurance National Committee for Quality Assurance None
Scoring Method Measure Type Stratification Risk Adjustment
Proportion Process Report a total rate, and each of the following age strata: Stratum 1: Patients age 46-49 by the end of the measurement period Stratum 2: Patients age 50-75 by the end of the measurement period None

Rate Aggregation

None

Improvement Notation

Higher score indicates better quality

Rationale

Clinical Recommendation Statement


Definition

Transmission Format

Applicable Value Sets

Category Value Set OID
Diagnosis Frailty Diagnosis 2.16.840.1.113883.3.464.1003.113.12.1074
Diagnosis Malignant Neoplasm of Colon 2.16.840.1.113883.3.464.1003.108.12.1001
Diagnostic Study, Performed CT Colonography 2.16.840.1.113883.3.464.1003.108.12.1038
Encounter, Performed Acute Inpatient 2.16.840.1.113883.3.464.1003.101.12.1083
Encounter, Performed Annual Wellness Visit 2.16.840.1.113883.3.526.3.1240
Encounter, Performed Emergency Department Visit 2.16.840.1.113883.3.464.1003.101.12.1010
Encounter, Performed Encounter Inpatient 2.16.840.1.113883.3.666.5.307
Encounter, Performed Frailty Encounter 2.16.840.1.113883.3.464.1003.101.12.1088
Encounter, Performed Home Healthcare Services 2.16.840.1.113883.3.464.1003.101.12.1016
Encounter, Performed Hospice Encounter 2.16.840.1.113883.3.464.1003.1003
Encounter, Performed Nonacute Inpatient 2.16.840.1.113883.3.464.1003.101.12.1084
Encounter, Performed Observation 2.16.840.1.113883.3.464.1003.101.12.1086
Encounter, Performed Office Visit 2.16.840.1.113883.3.464.1003.101.12.1001
Encounter, Performed Online Assessments 2.16.840.1.113883.3.464.1003.101.12.1089
Encounter, Performed Outpatient 2.16.840.1.113883.3.464.1003.101.12.1087
Encounter, Performed Palliative Care Encounter 2.16.840.1.113883.3.464.1003.101.12.1090
Encounter, Performed Preventive Care Services - Established Office Visit, 18 and Up 2.16.840.1.113883.3.464.1003.101.12.1025
Encounter, Performed Preventive Care Services-Initial Office Visit, 18 and Up 2.16.840.1.113883.3.464.1003.101.12.1023
Encounter, Performed Telephone Visits 2.16.840.1.113883.3.464.1003.101.12.1080
Intervention, Order Hospice Care Ambulatory 2.16.840.1.113883.3.526.3.1584
Intervention, Performed Hospice Care Ambulatory 2.16.840.1.113883.3.526.3.1584
Intervention, Performed Palliative Care Intervention 2.16.840.1.113883.3.464.1003.198.12.1135
Laboratory Test, Performed Fecal Occult Blood Test (FOBT) 2.16.840.1.113883.3.464.1003.198.12.1011
Laboratory Test, Performed FIT DNA 2.16.840.1.113883.3.464.1003.108.12.1039
Medication, Active Dementia Medications 2.16.840.1.113883.3.464.1003.196.12.1510
Patient Characteristic Ethnicity Ethnicity 2.16.840.1.114222.4.11.837
Patient Characteristic Payer Payer 2.16.840.1.114222.4.11.3591
Patient Characteristic Race Race 2.16.840.1.114222.4.11.836
Patient Characteristic Sex ONC Administrative Sex 2.16.840.1.113762.1.4.1
Procedure, Performed Colonoscopy 2.16.840.1.113883.3.464.1003.108.12.1020
Procedure, Performed Flexible Sigmoidoscopy 2.16.840.1.113883.3.464.1003.198.12.1010
Procedure, Performed Total Colectomy 2.16.840.1.113883.3.464.1003.198.12.1019
Symptom Frailty Symptom 2.16.840.1.113883.3.464.1003.113.12.1075

References


Disclaimer

Copyright


Source: https://ecqi.healthit.gov/ecqm/measures/cms130v1